[Prospects of studying the antiviral properties of cytokines].
Votiakov
V I
VI
Gribkova
N V
NV
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D016207:Cytokines / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D007372:Interferons / Q000494:pharmacology / Q000627:therapeutic use; D007378:Interleukins / Q000494:pharmacology / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology / Q000627:therapeutic use; D014777:Virus Diseases / Q000382:microbiology* / Q000628:therapy; D018406:Virus Physiological Phenomena; D014779:Virus Replication / Q000187:drug effects* / Q000502:physiology; D014780:Viruses / Q000187:drug effects*
D000998:Antiviral Agents; D016207:Cytokines; D007378:Interleukins; D014409:Tumor Necrosis Factor-alpha; D007372:Interferons
Perspektivy izucheniia antivirusnykh svoĭstv tsitokinov.